Consumers Union Model Clinical Trials Bill, October 2005
state_clinical.pdf | 23.6 kB
September 16, 2005
This article may be referred to as the “Patient Safety and Drug Review Transparency Act.” The purpose of this Act is to assure that information regarding clinical trials of prescription drugs is available to the public, physicians, researchers, and the state. Making information about drug trials and their results available on a national, publicly-accessible database will assure that the State, in its role as purchaser of prescription drugs and administrator of prescription drug programs can assure those drugs are safe. It will improve safety of all citizens of this state by assuring they have complete safety information about the prescription drugs they take.